Academic Journal
View in EDS
HTML Full Text

Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.

Bibliographic Details
Title: Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
Authors: Hafez Ghoran, Salar1,2 (AUTHOR) s_hafezghoran@yahoo.com, Calcaterra, Andrea3 (AUTHOR), Abbasi, Milad4 (AUTHOR), Taktaz, Fatemeh5,6 (AUTHOR), Nieselt, Kay7 (AUTHOR), Babaei, Esmaeil7,8 (AUTHOR) s_hafezghoran@yahoo.com
Source: Molecules. Aug2022, Vol. 27 Issue 16, p5236-5236. 29p.
Subject Terms: *ADJUVANT treatment of cancer, *CURCUMIN, *TURMERIC, *POISONS
Geographic Terms: UNITED States
Abstract: Throughout the United States, cancer remains the second leading cause of death. Traditional treatments induce significant medical toxic effects and unpleasant adverse reactions, making them inappropriate for long-term use. Consequently, anticancer-drug resistance and relapse are frequent in certain situations. Thus, there is an urgent necessity to find effective antitumor medications that are specific and have few adverse consequences. Curcumin is a polyphenol derivative found in the turmeric plant (Curcuma longa L.), and provides chemopreventive, antitumor, chemo-, and radio-sensitizing properties. In this paper, we summarize the new nano-based formulations of polyphenolic curcumin because of the growing interest in its application against cancers and tumors. According to recent studies, the use of nanoparticles can overcome the hydrophobic nature of curcumin, as well as improving its stability and cellular bioavailability in vitro and in vivo. Several strategies for nanocurcumin production have been developed, each with its own set of advantages and unique features. Because the majority of the curcumin-based nanoformulation evidence is still in the conceptual stage, there are still numerous issues impeding the provision of nanocurcumin as a possible therapeutic option. To support the science, further work is necessary to develop curcumin as a viable anti-cancer adjuvant. In this review, we cover the various curcumin nanoformulations and nanocurcumin implications for therapeutic uses for cancer, as well as the current state of clinical studies and patents. We further address the knowledge gaps and future research orientations required to develop curcumin as a feasible treatment candidate. [ABSTRACT FROM AUTHOR]
Copyright of Molecules is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=14203049&ISBN=&volume=27&issue=16&date=20220815&spage=5236&pages=5236-5264&title=Molecules&atitle=Curcumin-Based%20Nanoformulations%3A%20A%20Promising%20Adjuvant%20towards%20Cancer%20Treatment.&aulast=Hafez%20Ghoran%2C%20Salar&id=DOI:10.3390/molecules27165236
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 158911175
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hafez+Ghoran%2C+Salar%22">Hafez Ghoran, Salar</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> s_hafezghoran@yahoo.com</i><br /><searchLink fieldCode="AR" term="%22Calcaterra%2C+Andrea%22">Calcaterra, Andrea</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abbasi%2C+Milad%22">Abbasi, Milad</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Taktaz%2C+Fatemeh%22">Taktaz, Fatemeh</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nieselt%2C+Kay%22">Nieselt, Kay</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Babaei%2C+Esmaeil%22">Babaei, Esmaeil</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<i> s_hafezghoran@yahoo.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecules%22">Molecules</searchLink>. Aug2022, Vol. 27 Issue 16, p5236-5236. 29p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22ADJUVANT+treatment+of+cancer%22">ADJUVANT treatment of cancer</searchLink><br />*<searchLink fieldCode="DE" term="%22CURCUMIN%22">CURCUMIN</searchLink><br />*<searchLink fieldCode="DE" term="%22TURMERIC%22">TURMERIC</searchLink><br />*<searchLink fieldCode="DE" term="%22POISONS%22">POISONS</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22UNITED+States%22">UNITED States</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Throughout the United States, cancer remains the second leading cause of death. Traditional treatments induce significant medical toxic effects and unpleasant adverse reactions, making them inappropriate for long-term use. Consequently, anticancer-drug resistance and relapse are frequent in certain situations. Thus, there is an urgent necessity to find effective antitumor medications that are specific and have few adverse consequences. Curcumin is a polyphenol derivative found in the turmeric plant (Curcuma longa L.), and provides chemopreventive, antitumor, chemo-, and radio-sensitizing properties. In this paper, we summarize the new nano-based formulations of polyphenolic curcumin because of the growing interest in its application against cancers and tumors. According to recent studies, the use of nanoparticles can overcome the hydrophobic nature of curcumin, as well as improving its stability and cellular bioavailability in vitro and in vivo. Several strategies for nanocurcumin production have been developed, each with its own set of advantages and unique features. Because the majority of the curcumin-based nanoformulation evidence is still in the conceptual stage, there are still numerous issues impeding the provision of nanocurcumin as a possible therapeutic option. To support the science, further work is necessary to develop curcumin as a viable anti-cancer adjuvant. In this review, we cover the various curcumin nanoformulations and nanocurcumin implications for therapeutic uses for cancer, as well as the current state of clinical studies and patents. We further address the knowledge gaps and future research orientations required to develop curcumin as a feasible treatment candidate. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecules is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=158911175
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/molecules27165236
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 29
        StartPage: 5236
    Subjects:
      – SubjectFull: UNITED States
        Type: general
      – SubjectFull: ADJUVANT treatment of cancer
        Type: general
      – SubjectFull: CURCUMIN
        Type: general
      – SubjectFull: TURMERIC
        Type: general
      – SubjectFull: POISONS
        Type: general
    Titles:
      – TitleFull: Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hafez Ghoran, Salar
      – PersonEntity:
          Name:
            NameFull: Calcaterra, Andrea
      – PersonEntity:
          Name:
            NameFull: Abbasi, Milad
      – PersonEntity:
          Name:
            NameFull: Taktaz, Fatemeh
      – PersonEntity:
          Name:
            NameFull: Nieselt, Kay
      – PersonEntity:
          Name:
            NameFull: Babaei, Esmaeil
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 08
              Text: Aug2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 14203049
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Molecules
              Type: main
ResultId 1